Strategic leadership Certus Critical Care recently appointed a new CEO in March 2026, signaling a potential shift in strategic priorities and an openness to pursuing partnerships and larger scale sales opportunities with new leadership vision.

AI and precision The company focuses on AI-enabled endo-aortic catheters, automated critical care platforms and precision ventilation monitoring, presenting opportunities to collaborate with hospital systems and integrators seeking advanced monitoring and decision-support for critical care workflows.

Defense-funded validation Past Department of Defense grants and support have funded development of life-critical sensing and analytics platforms, suggesting credibility with government and large healthcare institutions and potential for contract-based procurement avenues.

Biocompatible materials Collaboration with Covestro for Makrolon polycarbonate indicates a focus on durable, biocompatible device components, opening doors to suppliers and manufacturers who serve regulated medical device ecosystems and require validated materials for airway monitoring products.

Early-stage growth With a small team and revenue in the low-to-mid single digits, Certus presents a high-potential partner for pilot deployments, speed-to-value programs, and co-development opportunities with large medtech players seeking innovative platforms to augment existing portfolios.